MicrobiologybioRxiv
C25-modified rifamycin derivatives with improved activity against Mycobacterium abscessus
L. Paulowski, K. S. H. Beckham, M. D. Johansen…·F. P. Maurer
This study develops a C25-modified rifamycin derivative, 5j, which resists enzymatic inactivation by ArrMab and shows potent antimicrobial activity against M. abscessus in vitro and in macrophages.
DOI 10.1093/pnasnexus/pgac130